Nanobiotix is trading at $41.83, up +5.47%, appearing primarily driven by biotech-sector strength.
- No new company-specific announcement or analyst action was identified for August 25, 2026; Nanobiotix’s investor-relations page shows its latest indexed update on July 30, 2026.
- Biotech ETF XBI rose 2.06% during regular trading.
- The rebound follows Nanobiotix’s 8.93% decline on August 24, 2026, amid broader risk-off pressure, suggesting volatility rather than a confirmed company catalyst.